The reagent is using for quantitative/qualitative real-time RT-PCR assay to detection and characterization of influenza, dengue, zika, chikungunya, and sars-COV-2 viruses. All assay perform on the ABI…
Ended Awarded
- Contract number
- HT009025FG0310038
- Awardee
-
Gibthai Company LIMITED UEI RC7VWH2MZKV3
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $44,581
Award facts
- Contract value 100% obligated
- $44,581.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 339112 Surgical and Medical Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 2 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Thailand
Award details come from SAM.gov/FPDS.
About this award
This is a firm fixed-price contract awarded by the Defense Health Agency (DHA) to Gibthai Company LIMITED, a for-profit organization based in Thailand. The $44,581.00 contract is for the supply of reagents used in quantitative/qualitative real-time RT-PCR assays to detect and characterize influenza, dengue, Zika, chikungunya, and SARS-CoV-2 viruses. The reagents are intended for use on the ABI PRISM 7500 Fast Sequence Detection System. This is a Blanket Purchase Agreement (BPA) call, which allows the DHA to procure these supplies as needed to support critical infectious disease testing and medical research programs, primarily in Thailand and Southeast Asia. The contract has no set-aside designation, indicating Gibthai Company LIMITED competed openly for this award. The company has a significant $1,216,000.00 BPA with the DHA that runs through September 2029, demonstrating its long-term strategic relationship and capability to provide specialized scientific equipment and supplies to the agency.
Description
The reagent is using for quantitative/qualitative real-time RT-PCR assay to detection and characterization of influenza, dengue, zika, chikungunya, and sars-COV-2 viruses. All assay perform on the ABI prism 7500 fast sequence detection system.
Quick answers
Who was awarded contract HT009025FG0310038?
HT009025FG0310038 was awarded to Gibthai Company LIMITED by Defense Health Agency (Department of Defense) on March 7, 2025.
How much is contract HT009025FG0310038 worth?
The government has obligated $44,581 on HT009025FG0310038.
Is contract HT009025FG0310038 an order under another contract?
Yes. HT009025FG0310038 is a BPA call under HT942524A0012, a blanket purchase agreement.
Was contract HT009025FG0310038 competed?
The extent of competition for HT009025FG0310038 was competed under sap. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award